Hans H Zingg, Daniel G Bichet, Charles W Bourque, World Congress on Neurohypophysial Hormones

Vasopressin and Oxytocin

Molecular, Cellular, and Clinical Advances
Herausgeber: Zingg, Hans H; Bichet, Daniel G; Bourque, Charles W

• Gebundenes Buch

Produktbeschreibung

This monograph provides a comprehensive overview of recent advances in the field of vasopressin and oxytocin. In the summer of 1997, scientists from over 20 countries congregated in Montreal for the 1997 World Congress of Neurohypophysial Hormones, a conference that united the fields of vasopressin, neurohypophysis, and oxytocin in a single joint meeting that gave rise to the present book. The organization of a joint meeting was prompted by several recent developments. Specifically the molecular characterization of the vasopressin/oxytocin receptor family made it mandatory to adopt an integrated view and to discuss the vasopressin/oxytocin ligand/receptor family as a whole. To ensure emphasis on novelty, the conference focused on advances made over the last two years and also included important contributions by scientist that had not previously been associated with the vasopressin/oxytocin field.

Produktdetails

• Verlag: Springer Nature Singapore
• Seitenzahl: 504
• Erscheinungstermin: 31. Oktober 1998
• Englisch
• Abmessung: 250mm x 175mm x 33mm
• Gewicht: 1042g
• ISBN-13: 9780306459283
• ISBN-10: 0306459280
• Artikelnr.: 24532223

Inhaltsangabe

Historical Overview: Vasopressin Receptors: A Historical Survey; S. Jard.
Biosynthesis of Vasopressin and Oxytocin. Cell-Specific Gene Expression in
Oxytocin and Vasopressin Magnocellular Neurons; H. Gainer. Hypothalamic
Transcription Factors and the Regulation of the
Hypothalamo-Neurohypophysial System; J.P.H. Burbach, et al. POU Domain
Factors in Neural Development; M.D. Schönemann, et al. Local Protein
Synthesis in Magnocellular Dendrites: Basic Elements and Their Response to
Hyperosmotic Stimuli; Dan Ma, J.F. Morris. Vasopressin Gene Expression in
Rat Choroid Plexus; A. Chodobski, et al. Neuronal Activity and Release.
Electrophysiological Distinctions between Oxytocin and Vasopressin Neurons
in the Supraoptic Nucleus; W.E. Armstrong, J.E. Stern. Mechanisms of
Neuroendocrine Cell Excitability; G.I. Hatton, Zhenhui Li. Properties of
the Transient K+ Current in Acutely Isolated Supraoptic Neurons from Adult
Rat; T.E. Fisher, C.W. Bourque. Gaba b Receptors and Supraoptic Neuronal
Activity; Q.J. Pittman, et al. Local Glutamatergic and Gabaergic Synaptic
Circuits and Metabotropic Glutamate Receptors in the Hypothalamic
Paraventricular and Supraoptic Nuclei; J.G. Tasker, et al. Progesterone
Regulates Hypothalamic Oxytocin mRNA Levels through Gamma Aminobutyric
Acid; A. Thomas, J.A. Amico. Differential Effects of the Neurosteroid
Pregnenolone Sulphate on Oxytocin and Vasopressin Neurones in Vitro; J.B.
Wakerley, C.M. Richardson. Regulation of Vasopressin Release by Ionotropic
Glutamate Receptor Agonists; D.J. Morsette, et al. Role of
N-Methy-D-Aspartate (NMDA) Receptors in Vasopressin and Oxytocin Responses
to Emotional Stimuli; K. Yagi, et al. Electrophysiological Studies of
Oxytocin Neurons in Organotypic Slice Cultures; P. Jourdain, et al.
Inhibitory Actions of Nociceptin (Orphanin FQ) on Rat Supraoptic Nucleus
Oxytocin and Vasopressin Neurones in Vitro; N. Doi, et al. New Aspects of
Firing Pattern Autocontrol in Oxytocin and Vasopressin Neurones; F. Moos,
et al. Intrahypothalamic Vasopressin Release: An Inhibitor of Systemic
Vasopressin Secretion? M. Ludwig, G. Leng. Differential Central and
Peripheral Release of Vasopressin and Oxytocin in Response to Swim Stress
in Rats; M. Engelmann, et al. Pregnancy and Aging: Two Model Systems with
Altered Release Patterns of Oxytocin and Vasopressin within the
Hypothalamus; I. Neumann, et al. Effect of Age and Testosterone on the
Vasopressin Response to Dehydration in F344BNF1 Male Rats; J.
Catudioc-Vallero, et al. Evidence for Nitric Oxide (NO) Actions throughout
the Forebrain Osmoresponsive Circuit; S.M. Luckman. Gaseous
Neurotransmitter Modulation of Vasopressin and Oxytocin Release; M.L.
Forsling, A. Grossman. Membrane Excitability in the Neurohypophysis; R.A.
Wilke, et al. Effects. Vasopressin's Depolarizing Action on Neonatal Rat
Spinal Lateral Horn Neurons May Involve Multiple Conductances; M. Kolaj,
L.P. Renaud. Vasopressin Action in the Mammalian Cerebral Cortex; R. Diaz
Brinton, et al. Oxytocin, Vasopressin, and the Neuroendocrine Basis of Pair
Bond Formation; T.R. Insel, et al. Central Oxytocin Neurotransmission:
Receptor Characterisation and Role in Modulating Limbic Circuits in the
Peripartum Period; C.D. Ingram, et al. Targeted Reduction of Oxytocin
Expression Provides Insights into Its Physiological Roles; W.S. Young III,
et al. Phenotypic Expression of and Oxytocin Peptide Null Mutation in Mice;
J.T. Winslow, et al. Antiproliferative Effect of Oxytocin through Specific
Oxytocin Receptors in Human Neuroblastoma and Astrocytoma Cell Lines; P.
Cassoni, et al. Phosphorylation of Proteins Induced in a Murine Pre-T Cell
Line by Neurohypophysial Peptides; H. Martens, et al. Signalling. Molecular
Pharmacology of Human Vasopressin Receptors; M. Thibonnier, et al.
Molecular Mechanisms Regulating the Effects of Oxytocin on Myometrial
Intracellular Calcium; B.M. Sanborn, et al. Receptors: Expression and
Regulation. Genomic and Non-Genomic Mechanisms of Oxytocin Receptor
Regulation; H.H. Zingg, et al. The Molecular Basis of Oxytocin and Oxytocin
Receptor Gene Expression in Reproductive Tissues; R. Ivell, et al.
Transcriptional Regulation of the Oxytocin Receptor Gene; T.L. Bale, D.M.
Dorsa. Female Reproduction in Mice Lacking the Prostaglandin F Receptor:
Roles of Prostaglandin and Oxytocin Receptors in Parturition; Y. Sugimoto,
et al. Expression of the Oxytocin Receptor and Oxytocin Gene in Human
Oocytes and Preimplantation Embryos; S. Stock, C. Osterlund. Vasopressin
Regulates Adrenal Functions by Acting through Different Vasopressin
Receptor Subtypes; E. Grazzini, et al. All Three Vasopressin Receptor
Sub-Types Are Expressed by Small-Cell Carcinoma; W.G. North, et al.
Receptors: Structure/Function. Processing and Ligand-Induced Modifications
of the V2 Vasopressin Receptor; H.M. Sadeghi, et al. Molecular Aspects of
Vasopressin Receptor Function; T. Schöneberg, et al. Mapping Peptide
Antagonist Binding Sites of the Human V1a and V2 Vasopressin Receptors; B.
Mouillac, et al. Structure/Function Studies on Receptors for Vasopressin
and Oxytocin; M. Wheatley, et al. Identification of a Constitutively Active
Mutant of the Human Oxytocin Receptor; B. Chini, et al. Identification of
Neurohypophysial Hormone Receptor Domains Involved in Ligand Binding and G.
Protein Coupling; R. Postina, et al. Mutations in the Vasopressin V2
Receptor and Aquaporin-2 Genes in Twelve Families with Congenital
Nephrogenic Diabetes Insipidus; R. Vargas-Poussou, et al. Functional Study
of Two V2 Vasopressin Mutant Receptors Related to NDI: P322S and P322H; D.
Morin, et al. Renal Actions of Vasopressin. Studies of Renal Aquaporin-2
Expression during Renal Escape from Vasopressin-Induced Antidiuresis; J.G.
Verbalis, et al. Prompt and Sustained Regulation of Aquaporin-2 by Arginine
Vasopressin in Collecting Duct Cells and Clinical Implication of Urinary
Excretion of Aquaporin-2; San-e Ishikawa, et al. Recent Advances in the
Understanding of Water Metabolism in Heart Failure; R.W. Schrier, P.Y.
Martin. Antagonists. Nonpeptide Antagonists for Vasopressin Receptors:
Pharmacology of SR 121463A, A New Potent and Highly Selective V2 Receptor
Antagonist; C. Serradeil-Le Gal. VPA-985, a Nonpeptide Orally Active and
Selective Vasopressin V2 Receptor Antagonist; P.S. Chan, et al. Effects of
Chronic AVP V2R Blockade in Congestive Heart Failure in Sheep: Comparison
with Chronic ACE Inhibition; M. Naitoh, et al. Vasopressin Induces Opposite
Changes in Blood Flow in the Skin and the Muscular Circulation; D. Hayoz,
et al. Discovery of Novel Selective Hypotensive Vasopressin Peptides: A New
Vasodilating Vasopressin Receptor? W.Y. Chan, et al. Safety, Tolerability,
and Pharmacokinetics of SR 49059, a V1a Vasopressin Receptor Antagonist,
after Repeated Oral Administration in Healthy Volunteers; R. Brouard, et
al. Evidence for an Involvement of Vasopressin in Mechanism of Primary
Dysmenorrhea and Effect of the Non-Peptide Vasopressin V1a Receptor
Antagonist, SR 49059, on the Uterus of Non-Pregnant Women; M. Akerlund, et
al. Progress in the Development of Oxytocin Antagonists for Use in Preterm
Labor; P.D. Williams, et al. Index.